← Back to all trials
Active Not Recruiting
NCT07912489
Effectiveness of Clockwise vs. Counter-Clockwise Osseodensification for Implant Site Preparation
Conditions: Osseodensification Drilling Technique
Sex: Female
Ages: 18 Years – 70 Years
Healthy volunteers: No
Phase: NA
Enrollment: 10
Sponsor: University of Science and Technology, Yemen
Location: UST Sanaa
Summary
This study aims to compare the primary stability of dental implants placed using two different rotational modes of the Densah burs (Clockwise Cutting vs. Counter-Clockwise Osseodensification) under a fully guided protocol. The primary outcomes are peak insertion torque and immediate implant stability quotient (ISQ).
Eligibility Criteria
Inclusion Criteria:
* Adult females aged 18 to 70 years.
* Able to provide written informed consent.
* Clinical indication for two endosseous dental implants at clinically comparable sites in the same participant.
* Edentulous sites (healed or not fully healed) with sufficient bone volume. Minor bone augmentation is permitted only if identical at both paired sites.
* Comparable paired sites regarding jaw, region, and planned implant diameter and length. The same implant dimensions must be used at both sites.
* Bone density corresponding to D2 or D3 (350-1250 HU); dense D1 sites are excluded.
* Good oral hygiene and periodontal stability.
* Adequate inter-arch space and mouth opening for fully guided surgery.
Exclusion Criteria:
* Uncontrolled systemic disease.
* Pregnancy or lactation.
* Previous high-dose radiotherapy to the jaws or current chemotherapy.
* Current intravenous antiresorptive therapy (e.g., bisphosphonates).
* Heavy smoking (\> 10 cigarettes/day) or substance abuse.
* Severe parafunctional habits.
* Active infection or untreated periodontitis at the planned sites.
* Sites requiring different grafting procedures between the two sides.
* D1 dense cortical bone or inability to perform the CCW protocol.
* Inability to obtain two comparable eligible sites.
Source: ClinicalTrials.gov (NCT07912489). StuddyBuddy aggregates publicly available trial information.